Biologics
AcadeMab Biomedical Inc.
Products
- AM-928 is a first-in-class antibody that eliminates cancer recurrence at its source. Following a successful Phase I trial, we are now accelerating into Phase II combination trials.
- We provide patented GMP-grade cationic lipids as critical APIs for the global nucleic acid drug market.
Interests
- Clinical Trial Collaboration
- Out-Licensing
- CDMO
- Collaborative R&D
- Co-Development
Contact Information
- NamePi-Chun Li
- PositionDirector of R&D
- Tel+886-2-2789-1212 #800
- Emailpichun.li@academab.com
- https://www.academab.com/en/